U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07560618) titled 'Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.' on April 23.
Brief Summary: This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
ITCH
Atopic Dermatitis
Intervention:
DRUG: Roflumilast Cream 0.15%
topically applied to the affected areas once daily
Recruitment S...